Patients diagnoised with basal cells carcinoma, also known as skin cancer , will be enrolled to evaluate new treatments for this skin cancer. Clinical trial participants will be monitored closely by medical professionals for the duration of the study. The goal of this basel cell carcinoma clinical trial is to develop better understanding of basel cell carcinoma and develop safe and effective therapies.
14 weeks to 16 weeks depending on study
Subject compensation and travel assistance may be available. Study medication, study related exams, and lab tests will be provided at no cost.
For general questions regarding our clinical trials, please contact our team at email@example.com or fill out the contact form below.
A clinical trial is a research study conducted with human volunteers to test the effectiveness and safety of new drugs, devices, or interventions. Our Clearlyderm clinical trials focus on skin conditions such as psoriasis, acne, rosacea, or atopic dermatitis (eczema).
To enroll in one of our clinical trials, contact our office. You will need to review and complete informed consent documents and complete screening procedures prior to participation.
Like any medical treatment, potential risks exist. However, participants are informed of these risks prior to starting the clinical trials and receive monitoring and follow-up care throughout the trial duration if selected to participate.
This clinical trial is focused on finding efficient and less invasive ways to treat basal cell carcinoma. Basal cell carcinoma (BCC) is the most common type of skin cancer that develops due to sun exposure.
Patients who have recently been diagnosed with a basal cell carcinoma and have not yet received treatment.
About 12-14 weeks
Yes, subjects enrolled in this clinical trial will receive compensation per attended visit.